Prot #D4190C00023: A Phase 1b Study to Evaluate the Safety and Efficacy of MEDI4736 as Monotherapy and in Combination with Tremelimumab or AZD9150 in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date4/29/164/29/19

Funding

  • ICON Clinical Research, LLC (Prot #D4190C00023)
  • MedImmune, LLC (Prot #D4190C00023)